Sotorasib Edges Closer to Approval.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2021-0309
Abstract: The KRASG12C inhibitor sotorasib continues to impress in non-small cell lung cancer: In the phase II CodeBreak 100 trial, the agent elicited responses in more than a third of patients and led to a median… read more here.
Keywords: closer approval; approval; edges closer; sotorasib ... See more keywords